Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.

Show more authors
+ 16
Jesper van Breeschoten
Michel W J M Wouters
Doranne L Hilarius
John B Haanen
Christian U Blank
Maureen J B Aarts
Franchette W P J van den Berkmortel
Jan-Willem B de Groot
Geke A P Hospers
Ellen Kapiteijn
Djura Piersma
Roos S van Rijn
Karijn P M Suijkerbuijk
Willeke A M Blokx
Bert-Jan J Ten Tije
Astrid A M van der Veldt
Art Vreugdenhil
Marye J Boers-Sonderen
Alfonsus J M van den Eertwegh

More about this publication

British journal of cancer

Volume 126
Issue nr. 9
Pages 1362
Publication date 01-05-2022

Full text links

Publisher website (DOI) 10.1038/s41416-022-01772-z
Europe PubMed Central 35256756
Pubmed 35256756

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.